Sympathetic Ophthalmia

REFERENCES

• Chu XK, Chan CC. Sympathetic ophthalmia: To the twenty-first century and beyond. J Ophthalmic Inflamm Infect. 2013; 3(1):49.
   PubMedGoogle Scholar
• Castiblanco C, Adelman RA. Imaging for sympathetic ophthalmia: Impact on the diagnosis and management. Int Ophthalmol Clin. 2012; 52(4):173–181.
   PubMedGoogle Scholar
• Arevalo JF, Garcia RA, Al-Dhibi HA, et al. Update on sympathetic ophthalmia. Middle East Afr J Ophthalmol. 2012; 19(1):13–21.
   PubMedGoogle Scholar
• Chaithanyaa N, Devireddy SK, Kishore Kumar RV, et al. Sympathetic ophthalmia: A review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 113(2):172–176.
   PubMed Web of Science ®Google Scholar
• Chang GC, Young LH. Sympathetic ophthalmia. Semin Ophthalmol. 2011; 26(4–5):316–320.
   PubMed Web of Science ®Google Scholar
• Sen HN, Nussenblatt RB. Sympathetic ophthalmia: What have we learned? Am J Ophthalmol. 2009; 148(5):632–633
   PubMed Web of Science ®Google Scholar
• Castiblanco CP, Adelman RA. Sympathetic ophthalmia. Graefes Arch Clin Exp Ophthalmol. 2009; 247(3):289–302.
   PubMed Web of Science ®Google Scholar
• Galor A, Davis JL, Flynn HW Jr, et al. Sympathetic ophthalmia: Incidence of ocular complications and vision loss in the sympathizing eye. Am J Ophthalmol. 2009; 148(5):704–710.
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000; 84(3):259–263.
   PubMed Web of Science ®Google Scholar
• Kilmartin DJ, Dick AD, Forrester JV. Sympathetic ophthalmia risk following vitrectomy: Should we counsel patients? Br J Ophthalmol. 2000; 84(5):448–449.
   PubMed Web of Science ®Google Scholar
• Chan CC, Roberge RG, Whitcup SM, et al. 32 cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md., from 1982 to 1992. Arch Ophthalmol. 1995; 113(5):597–600.
   PubMedGoogle Scholar
• Brouzas D, Koutsandrea C, Moschos M, et al. Massive choroidal hemorrhage after intravitreal administration of bevacizumab (Avastin) for AMD followed by controlateral sympathetic ophthalmia. Clin Ophthalmol. 2009; 3:457–459.
   PubMedGoogle Scholar
• Guerriero S, Montepara A, Ciracì L, et al. A case of sympathetic ophthalmia after a severe acanthamoeba keratitis. Eye Contact Lens. 2011; 37(6):374–376.
   PubMed Web of Science ®Google Scholar
• Buller AJ, Doris JP, Bonshek R, et al. Sympathetic ophthalmia following severe fungal keratitis. Eye (Lond). 2006; 20(11):1306–1307.
   PubMed Web of Science ®Google Scholar
• Shen J, Fang W, Jin XH, et al. Sympathetic ophthalmia caused by a severe ocular chemical burn: A case report and literature review. Int J Clin Exp Med. 2015; 8(2):2974–2978.
   PubMed Web of Science ®Google Scholar
• Brour J, Desjardins L, Lehoang P, et al. Sympathetic ophthalmia after proton beam irradiation for choroïdal melanoma. Ocul Immunol Inflamm. 2012; 20(4):273–276.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Soong TK, Salvi S, et al. Sympathetic ophthalmia after ruthenium plaque brachytherapy. Br J Ophthalmol. 2007; 91(3):399–401.
   PubMed Web of Science ®Google Scholar
• Margo CE, Pautler SE. Granulomatous uveitis after treatment of a choroidal melanoma with proton-beam irradiation. Retina. 1990; 10(2):140–143.
   PubMed Web of Science ®Google Scholar
• Fries PD, Char DH, Crawford JB, et al. Sympathetic ophthalmia complicating helium ion irradiation of a choroidal melanoma. Arch Ophthalmol. 1987; 105(11):1561–1564.
   PubMedGoogle Scholar
• Edwards TL, McKelvie P, Walland MJ. Sympathetic ophthalmia after diode laser cyclophotocoagulation: Now an issue in informed consent. Can J Ophthalmol. 2014; 49(4):e102–104.
   PubMed Web of Science ®Google Scholar
• Aujla JS, Lee GA, Vincent SJ, et al. Incidence of hypotony and sympathetic ophthalmia following trans-scleral cyclophotocoagulation for glaucoma and a report of risk factors. Clin Exp Ophthalmol. 2013; 41(8):761–772.
   PubMed Web of Science ®Google Scholar
• Roberts MA, Rajkumar V, Morgan G, et al. Sympathetic ophthalmia secondary to cyclodiode laser in a 10-year-old boy. J AAPOS. 2009; 13(3):299–300.
   PubMed Web of Science ®Google Scholar
• Jonas JB, Back W, Sauder G, et al. Sympathetic ophthalmia in vater association combined with persisting hyperplastic primary vitreous after cyclodestructive procedure. Eur J Ophthalmol. 2006; 16(1):171–172.
   Web of Science ®Google Scholar
• Kumar N, Chang A, Beaumont P. Sympathetic ophthalmia following ciliary body laser cyclophotocoagulation for rubeotic glaucoma. Clin Exp Ophthalmol. 2004; 32(2):196–198.
   PubMed Web of Science ®Google Scholar
• Biswas J, Fogla R. Sympathetic ophthalmia following cyclocryotherapy with histopathologic correlation. Ophthalmic Surg Lasers. 1996; 27(12):1035–1038.
   PubMedGoogle Scholar
• Bechrakis NE, Müller-Stolzenburg NW, Helbig H, et al. Sympathetic ophthalmia following laser cyclocoagulation. Arch Ophthalmol. 1994; 112(1):80–84.
   PubMedGoogle Scholar
• Bilyk JR. Enucleation, evisceration, and sympathetic ophthalmia. Curr Opin Ophthalmol. 2000; 11(5):372–386.
   PubMedGoogle Scholar
• Manandhar A. Sympathetic ophthalmia: Enucleation or evisceration? Nepal J Ophthalmol. 2011; 3(2):181–187.
   PubMedGoogle Scholar
• Rishi E, Rishi P, Appukuttan B, et al. Sympathetic ophthalmitis following vitreoretinal surgery: Does antecedent trauma make a difference? Indian J Ophthalmol. 2015; 63(9):692–698
   PubMed Web of Science ®Google Scholar
• Elschnig A. Studies on sympathetic ophthalmia, II: The antigenic effect of eye pigments. Graefes Arch Clin Exp Ophthalmol. 1910; 76:509–546.
   Google Scholar
• Kilmartin DJ, Wilson D, Liversidge J, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol. 2001; 85(3):281–286.
   PubMed Web of Science ®Google Scholar
• Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci. 2005; 46(11):4245–4250.
   PubMed Web of Science ®Google Scholar
• Aziz HA, Flynn HW Jr, Young RC, et al. Sympathetic ophthalmia: Clinicopathologic correlation in a consecutive case series. Retina. 2015; 35(8):1696–1703.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: Recommendations of an expert panel. Am J Ophthalmol. 2000; 130(4):492–513.
   PubMed Web of Science ®Google Scholar
• Mahajan S, Invernizzi A, Agrawal R, et al. Multimodal imaging in sympathetic ophthalmia. Ocul Immunol Inflamm. 2017; 25(2):152–159.
   Google Scholar
• Payal AR, Foster CS. Long-term drug-free remission and visual outcomes in sympathetic ophthalmia. Ocul Immunol Inflamm. 2017; 25(2):190–195.
   Google Scholar
• Goudot M, Groh M, Salah S, et al. Lymphocytic meningitis in patients with sympathetic ophthalmia. Ocul Immunol Inflamm. 2017; 25(2):196–201.
   Google Scholar
• Kempen JH, Gangaputra S, Daniel E, et al. Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: A critical assessment of the evidence. Am J Ophthalmol. 2008; 146(6):802–812.
   PubMed Web of Science ®Google Scholar